Effect of Neutral Endopeptidase 24.11 Inhibition on Myocardial Ischemia/Reperfusion Injury: The Role of Kinins
- 1 February 1997
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Cardiovascular Pharmacology
- Vol. 29 (2), 250-256
- https://doi.org/10.1097/00005344-199702000-00014
Abstract
Angiotensin-converting enzyme inhibitors (ACEi) protect the heart against ischemia/reperfusion injury. Part of this cardioprotective effect may be mediated through kinins. Because kinins are also metabolized by neutral endopeptidase (NEP) 24.11 in vivo, we hypothesized that (a) inhibition of NEP-24.11 would afford cardioprotection similar to that of ACEi and potentiate the effect of ACEi; and (b) these effects are mediated by kinins or atrial natriuretic peptide (ANP) or both. In Lewis inbred rats, the left anterior descending coronary artery (LAD) was occluded for 30 min, followed by 120-min reperfusion. Immediately before reperfusion, rats received vehicle, the ACEi ramiprilat, the NEP-24.11 inhibitor (NEPi) CGS24592, or both. To test whether the effect of NEPi could be suppressed by blocking kinins or ANP, the kinin-receptor antagonist icatibant or ANP antagonist HS-142-1 was administered before LAD occlusion. In controls, infarct size/risk area was 69 ± 4%; NEPi reduced this to 24 ± 4% (p < 0.001) and ramiprilat to 20 ± 3% (p < 0.001). NEPi did not potentiate the effect of ramiprilat (infarct size/risk area, 18 ± 4%). The protective effect of NEPi was blocked by icatibant; infarct size/risk area, 61 ± 4%, significantly larger than NEPi alone (p < 0.001) but no different from controls. The effect of NEPi was slightly diminished by the ANP antagonist HS-142-1 (infarct size/risk area, 35 ± 3%; NS vs. NEPi alone). Thus NEP-24.11 participates in catabolism of kinins in the heart; inhibition of NEP-24.11 may increase cardiac kinins, which are responsible for the cardioprotective effect of NEPi.Keywords
This publication has 20 references indexed in Scilit:
- Paracrine Systems in the Cardioprotective Effect of Angiotensin-Converting Enzyme Inhibitors on Myocardial Ischemia/Reperfusion Injury in RatsHypertension, 1996
- Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogsCardiovascular Research, 1993
- Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemiaThe FASEB Journal, 1991
- Modulation of Leukocyte-Mediated Myocardial Reperfusion InjuryAnnual Review of Physiology, 1990
- Mechanism of myocardial "stunning".Circulation, 1990
- Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarctionAmerican Heart Journal, 1990
- Antagonizing bradykinin (BK) obliterates the cardioprotective effects of bradykinin and angiotensin-converting enzyme (ACE) Inhibitors in ischemic heartsDrug Development Research, 1990
- Role of angiotensin converting enzyme and other peptidases in in vivo metabolism of kinins.Hypertension, 1989
- Protective Effect of Angiotensin Converting Enzyme Inhibitors (CEI): Captopril and Perindopril on Vulnerability to Ventricular Fibrillation During Myocardial Ischemia and Reperfusion in RatClinical and Experimental Hypertension. Part A: Theory and Practice, 1987
- Myocardial reperfusion: a double-edged sword?JCI Insight, 1985